Sagimet Bioscience's acne treatment, denifanstat, has shown success in a Phase III trial led by Ascletis Bioscience in China. The drug demonstrated efficacy in reducing skin lesions and inflammatory lesions with a good safety profile.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing